Case Report: Peripheral blood T cells and inflammatory molecules in lung cancer patients with immune checkpoint inhibitor-induced thyroid dysfunction: Case studies and literature review

Immunotherapy has changed the paradigm of cancer treatment, yet immune checkpoint inhibitors (ICIs) such as PD-1/PD-L1 monoclonal antibodies may cause immune-related adverse events (irAEs) in some patients. In this report, two non-small cell lung cancer (NSCLC) patients treated with nivolumab presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Marie, Mona A., McCallen, Justin D., Hamedi, Zahra S., Naqash, Abdul Rafeh, Hoffman, Alexander, Atwell, Druid, Amara, Suneetha, Muzaffar, Mahvish, Walker, Paul R., Yang, Li V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768626/
https://www.ncbi.nlm.nih.gov/pubmed/36568170
http://dx.doi.org/10.3389/fonc.2022.1023545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768626/
https://www.ncbi.nlm.nih.gov/pubmed/36568170
http://dx.doi.org/10.3389/fonc.2022.1023545

Ejemplares similares